Alison Marshall Winters, - Speech-Language Pathologist in Danville, IN

Alison Marshall Winters, is a Speech-language Pathologist based in Danville, Indiana. Alison Marshall Winters is licensed to practice in Indiana (license number 22006710A) and her current practice location is 1001 Sycamore Ln, Danville, Indiana. She can be reached at her office (for appointments etc.) via phone at (317) 745-7503.

NPI number for Alison Marshall Winters is 1225538952 and her current mailing address is 355 N 4th St, Zionsville, Indiana. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1225538952.

Contact Information

Alison Marshall Winters,
1001 Sycamore Ln,
Danville, IN 46122-1474
(317) 745-7503
Not Available



Healthcare Provider's Profile

Full NameAlison Marshall Winters
GenderFemale
SpecialitySpeech-language Pathologist
Location1001 Sycamore Ln, Danville, Indiana
Accepts Medicare AssignmentsDoes not participate in Medicare Program. She may not accept medicare assignment.
  NPI Data:
  • NPI Number: 1225538952
  • Provider Enumeration Date: 02/19/2018
  • Last Update Date: 02/19/2018

Medical Identifiers

Medical identifiers for Alison Marshall Winters such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1225538952NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
235Z00000XSpeech-language Pathologist 22006710A (Indiana)Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Alison Marshall Winters is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Alison Marshall Winters,
355 N 4th St,
Zionsville, IN 46077-1335

Ph: (812) 528-1576
Alison Marshall Winters,
1001 Sycamore Ln,
Danville, IN 46122-1474

Ph: (317) 745-7503

News Archive

Ranbaxy secures FDA approval for quinapril hydrochloride + hydrochlorothiazide tablets

Ranbaxy Pharmaceuticals has announced approval from the U.S. Food and Drug Administration to manufacture and market Quinapril Hydrochloride & Hydrochlorothiazide (Quinapril + HCTZ) Tablets, 10mg/12.5mg, 20mg/12.5mg and 20mg/25mg.

Art-based interventions may help reduce adverse physiological and psychological outcomes

The Foundation for Art & Healing today releases the proceedings from its groundbreaking Arts and the Heart Roundtable (AHR), a gathering of luminaries from the medical, arts and public health sectors regarding the connection between creative engagement and cardiac health. Held during the summer of 2009 in New York, the goal of the meeting was to draw on research and clinical expertise as well as the direct experiences of cardiac patients who have found creative endeavors to aid in their own personal healing processes.

PET/MRI reduces radiation exposure, improves lesion detectability in select cancers

A single-center observational study of more than 1,000 oncological examinations has demonstrated that positron emission tomography/magnetic resonance imaging (PET/MRI) facilitates cancer staging as well as PET/computed tomography (PET/CT) and improves lesion detectability in select cancers, potentially helping to promote fast, efficient local and whole-body staging in one step.

Accentia enters strategic agreement with Baxter to purchase Cytoxan drug

Accentia Biopharmaceuticals, Inc. today announced a strategic agreement with Baxter Healthcare Corporation to provide Accentia with the exclusive, worldwide right to purchase Baxter's cyclophosphamide, which is marketed under the brand name Cytoxan, for the treatment of designated autoimmune diseases including multiple sclerosis.

Tel Aviv University says caffeine and alcohol can change part of DNA linked to aging, cancer

​Coffee and beer are polar opposites in the beverage world. Coffee picks you up, and beer winds you down.

Read more News

› Verified 8 days ago


Speech-Language Pathologist in Danville, IN

Mrs. Hillary N Rudolphi, CCC-SLP
Speech-Language Pathologist
Medicare: Not Enrolled in Medicare
Practice Location: 3380 E Main St, Danville, IN 46122
Phone: 317-718-0089    
Tammy Navarro, M.S., CCC-SLP
Speech-Language Pathologist
Medicare: Not Enrolled in Medicare
Practice Location: 1000 E Main St, Danville, IN 46122
Phone: 317-745-3414    
Sarah Wanger, M.S., CFY-SLP
Speech-Language Pathologist
Medicare: Not Enrolled in Medicare
Practice Location: 3380 E Main St, Danville, IN 46122
Phone: 317-718-0089    Fax: 317-718-0097
Ms. Jennifer Laine Hagemeyer, CCC-SLP
Speech-Language Pathologist
Medicare: Medicare Enrolled
Practice Location: 1001 Sycamore Ln, Danville, IN 46122
Phone: 317-745-4715    
Mrs. Teresa A Nering, SLP
Speech-Language Pathologist
Medicare: Medicare Enrolled
Practice Location: 1001 Sycamore Ln, Danville, IN 46122
Phone: 317-745-7066    
Michelle Jordan, M.A., CCC-SLP
Speech-Language Pathologist
Medicare: Not Enrolled in Medicare
Practice Location: 1001 Sycamore Ln, Danville, IN 46122
Phone: 317-745-4715    Fax: 317-745-8271

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.